Janover to Present at Webull LIVE! Financial Technology Investment Webinar on December 20th
Boca Raton, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform […]
Round Table Pizza Debuts in Houston
Beloved Pizza Chain Expands Texas Footprint in Richmond Suburb LOS ANGELES, Dec. 19, 2023 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. […]
Global Mofy Metaverse Limited together with China’s leading video platform Present AI-themed Short Film Series
– Jointly Support Growth of Promising Chinese Young Directors and Sci-Fi Films Beijing, CHINA, Dec. 19, 2023 (GLOBE NEWSWIRE) — […]
LiveOne (Nasdaq: LVO) Issues Fiscal 2025 Revenue Guidance of $140 – $155M with $16 – $20M of Adjusted EBITDA*
– Audio Division, consisting of Slacker Radio and PodcastOne (Nasdaq: PODC), forecasts to combine for $130 – $140M of revenues […]
Navitas Opening Ceremony and Investor Day 2023 at Torrance HQ
TORRANCE, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry […]
Biodexa Announces Pricing of $5.2 Million Underwritten Public Offering
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) CARDIFF, United Kingdom, Dec. 19, 2023 (GLOBE NEWSWIRE) — Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), […]
Nature’s Sunshine Recognized with Best Company Culture Award
LEHI, Utah, Dec. 19, 2023 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health […]
Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs
MIAMI, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on […]
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
BOSTON and ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical […]
Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation
FLORHAM PARK, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]
